Surfactant is pleural fluid.
type II alveolar cells
Respiratory Distress Syndrome
surfactant
A deficiency of lung surfactant may result in difficulty breathing, decreased lung compliance, and an increased risk of lung collapse or atelectasis. It can also lead to respiratory distress syndrome, especially in premature infants. Treatment often involves providing artificial surfactant therapy.
The fatty molecule on the respiratory membrane is called a surfactant. Surfactant helps reduce the surface tension of the fluid lining the alveoli in the lungs, allowing for easier expansion and preventing the alveoli from collapsing during exhalation.
B. an artificial surfactant.
breathing. It causes respiratory distress.
No, parietal membranes do not cover the surface of organs. Parietal membranes line the body cavities, while visceral membranes cover the surface of organs within those cavities.
Respiratory distress syndrome (RDS) is a common respiratory disorder in neonates, especially premature babies. It is caused by immature lung development and lack of surfactant, resulting in breathing difficulties. Treatment may include oxygen therapy, mechanical ventilation, and surfactant replacement therapy.
Mucous membranes line the digestive and respiratory tracts.
Surfactant helps reduce surface tension within the alveoli, thus preventing each alveolus from callapsing as air moves in and out during respiration.
The three main membranes in the human body are the mucous membrane, serous membrane, and synovial membrane. Mucous membranes line cavities that are open to the external environment, such as the respiratory and digestive tracts. Serous membranes line closed body cavities and cover organs, reducing friction between them. Synovial membranes surround joints, producing synovial fluid to lubricate and cushion the joint.